The Use of Impedance Index in the Surveillance of PTFE Femorodistal Grafts

BACKGROUND: Impedance is the equivalent in pulsatile flow of resistance in steady flow. The impedance index has been used successfully in the surveillance of vein grafts, but its use has not been reported in the context of PTFE femorodistal grafts. METHODS: Twenty-eight patients (median age 68 years (IQR 59-73 years) and 20 men) undergoing 28 PTFE femorodistal grafts with a vein cuff were evaluated prospectively comparing the impedance index with standard duplex graft surveillance. All grafts were performed for critical ischaemia. At risk grafts were identified and treated appropriately after angiography. RESULTS: The primary patencies at 1 and 2 years were 82% and 50% respectively. Duplex identified 11 at risk grafts of which 9 had an identifiable correctable lesion. Impedance analysis overpredicted at risk status when compared with duplex in the immediate postoperative phase and was unsuccessful in detecting inflow disease or low flow relating to cardiac failure. Using a threshold index of 0.5, impedance analysis has a sensitivity of 87%, specificity of 88%, with positive and negative predictive values of 76% and 94% respectively. CONCLUSIONS: Impedance index is a non-invasive method of graft surveillance which is applicable to PTFE femorodistal bypasses and may be a useful alternative to duplex although formal validation studies will be required.     

Coating with paclitaxel improves graft survival in a porcine model of haemodialysis graft stenosis.

BACKGROUND: Most commonly resulting from intimal hyperplasia at the venous anastomosis, stenosis leading to thrombosis is a major cause of failure of polytetrafluoroethylene (PTFE) dialysis grafts. We recently reported that coating haemodialysis grafts with paclitaxel could reduce neointimal hyperplasia. This study tested whether paclitaxel-coating could prolong graft survival in a porcine model. METHODS: PTFE grafts were double-coated with paclitaxel. Bilateral grafts were created between the carotid arteries and the external jugular veins, and we evaluated graft survival by weekly measurements of blood flow for 12 weeks. RESULTS: We successfully implanted four pairs of paclitaxel-coated grafts and four pairs of control grafts in eight Landrace pigs. One control pig had to be euthanized at 4 weeks after graft placement. The grafts in the other three controls and four paclitaxel pigs survived until harvesting of the grafts. All paclitaxel-coated grafts remained patent for 12 weeks without decrease of blood flow. Median blood flow was 702 ml/min at three weeks and 818 ml/min at 12 weeks after placement. In contrast, the four control grafts lost luminal patency at 5, 6, 6 and 8 weeks, respectively. In Kaplan-Meier analysis, paclitaxel-coated grafts showed better survival than uncoated grafts (P = 0.011). CONCLUSIONS: Double-coating with paclitaxel improved graft survival. Coated PTFE grafts may be effective for the prevention of graft failure in patients on haemodialysis.     

Mechanical Determinants of Graft Kinking

Vascular grafts can be twisted inadvertently during implantation. If twisted excessively, they may kink and obstruct flow. In this study, in vitro experiments were performed to identify the mechanical factors that determine graft kinking. These included graft material, graft length, graft diameter, graft wall thickness, perfusion pressure, and flow rate. Six-millimeter-diameter saphenous veins were obtained from humans at autopsy. Six-millimeter standard-wall and 6-mm thin-wall polytetrafluoroethylene (PTFE) grafts also were obtained. Both fixed-length and stretchable PTFE grafts were examined. Grafts 15, 30, 50, and 70 cm in length were evaluated. Finally, PTFE grafts 4, 6, 8, 10, 12, and 14 mm in diameter were studied to determine the effect of diameter. The vessels were mounted horizontally in vitro and were perfused with saline at 50, 100, or 150 mmHg pressure at low (49 mL/min), medium (105 mL/min), and high (239 mL/min) flow rates. Each graft was twisted 90 degrees, then subjected to perfusion for 15 sec. Pressure and flow were interrupted, and an additional 90 degrees twist was imposed for another 15 sec. This sequence was repeated until a visible kink developed. We conclude from our results that, when constructing a bypass, particular care should be taken with vein, short grafts, thin-wall grafts, and large-diameter grafts, as these are especially susceptible to kinking.     

Operative transluminal laser angioplasty as the sole treatment for late stenoses of femorodistal artery bypass graft: Experimental and clinical studies

To determine the role of Nd:YAG laser thermal angioplasty as the sole treatment for late stenoses of femorodistal artery bypass graft, the lasing effect of a larger size of hot-tip probe (3, 4, and 5 mm) was experimentally studied in vitro. For an adequate lasing effect, 30 watts of laser power output for 3 seconds was needed for the 3 mm probe, 40 watts for the 4 mm probe, and 50 watts for the 5 mm probe, respectively. Based on these results, we used Nd:YAG laser thermal angioplasty alone for 25 grafts, including 16 polytetrafluoroethylene (PTFE) grafts, eight saphenous vein grafts, and one externally supported (EXS) Dacron graft in which the stenotic lesions were detected by deterioration of the Doppler flow waveform pattern or a significant fall in the ankle/brachial pressure index (ABPI). Follow-up was from 3 to 24 months (average of 9 months) for PTFE grafts, from 5 to 21 months (average of 11 months) for saphenous vein grafts, and 13 months for the EXS Dacron graft following femorodistal artery reconstructions. Stenotic lesions were most common in the distal anastomotic sites: 11 PTFE grafts, three saphenous vein grafts, and one EXS Dacron graft. Among these, 13 grafts showed a type II flow waveform pattern at the time of surgery. Clinical success was achieved in 12 of the PTFE grafts (75%), in five of the vein grafts (62.5%), and in the single EXS Dacron graft. Four PTFE and three saphenous vein grafts failed subsequent to repeat intraoperative balloon angioplasty in three and graft extension in three and one graft interposition. Perforation occurred in only one vein graft. Continuing patency has now been maintained for up to 25 months after lasing. Nd:YAG laser thermal angioplasty using a 3 to 5 mm hot-tip probe is effective as the sole procedure for widening a stenotic lesion and improving patency after femorodistal artery reconstruction.     

Comparison between externally stented and unstented PTFE vascular grafts

It has been suggested that external stenting of synthetic vascular prosthetic material may improve patency rates in the low flow situation or across joints. This study compared externally stented polytetrafluoroethylene (PTFE) vascular grafts placed across the hip joint in dogs with nonstented PTFE grafts in regard to patency. Twenty animals underwent bilateral common iliac to common femoral artery bypass with proximal ligation of the femoral artery. In each animal one groin was randomly assigned to receive stented PTFE and the other nonstented PTFE. One animal was sacrificed at 2 weeks for graft infection. Nineteen animals received 38 grafts that remained in place 90-120 days. Patency was confirmed with angiography prior to sacrifice. Overall patency was 65 per cent with no significant difference between the two types of graft. Eighteen of 19 dogs (95%) had both the stented and nonstented PTFE grafts either open or closed. It is concluded that intrinsic factors, rather than external graft support, are a more important influence on graft patency in this model.     

The use of long synthetic microvascular grafts to vascularise free flaps in rabbits

A 5 cm length of 2 mm internal diameter (i.d.) synthetic, expanded polytetrafluoroethylene (PTFE, or Gore-Tex) vascular graft was used to connect 25 rabbit inferior epigastric flaps to the contralateral femoral vessels. In 15 animals an expanded PTFE graft connected the opposite femoral artery to the flap while the ipsilateral venous drainage remained intact. In the remaining 10 animals an expanded PTFE graft was used to replace the venous drainage of the flap and connected to the opposite femoral vein while the ipsilateral femoral artery supplied the flap. Flap survival and graft patency were evaluated over 3 weeks. Ten of 15 flaps with intra-arterial grafts survived at 3 weeks (67%). Only 27% (4/15) of their supplying grafts remained patent for 3 weeks, although 67% (10/15) were patent at 10 days. All 10 flaps, where expanded PTFE grafts replaced venous outflow, failed within 36 hours. At exploration these grafts were thrombosed or collapsed. In conclusion, currently available 2 mm (i.d.) expanded PTFE vascular graft cannot maintain patency in a low blood flow circulation supplying an isolated free flap.     

Flow waveform analysis and long-term results of autogenous saphenous vein and polytetrafluoroethylene grafts in 140 arterial reconstructions of the lower limbs

In previous work we have found that the outcome of grafts in the lower limbs correlated with the flow waveform pattern of the artery. We have retrospectively reviewed 140 femoro-popliteal bypass operations involving the use of 75 saphenous vein grafts and 65 polytetrafluoroethylene (PTFE) grafts. For grafts with type 0 or I flow waveform pattern the patency at 4 years (56%) was superior to grafts with the type II, III or IV flow waveform (35%) patterns (P less than 0.05). For saphenous vein grafts with type 0 or I flow, the patency rate was 78% at 3 years and 69% at 5 and 8 years. In contrast with type II, III or IV flow the patency rate was 52% at 3 years, 48% at 5 years and 34% at 8 years, with a statistical significance at 4 years (P less than 0.05). PTFE grafts with type 0 or I flow showed a tendency toward an increased patency which was not significant in comparison with the grafts with type II, III or IV flow (P = 0.12). Saphenous vein grafts with type II flow patterns had an increased occlusive rate in the first year whereas PTFE grafts had the same tendency within 2 years. In both types of graft, early occlusions within a month of operation were encountered in grafts with a type III or IV flow waveform pattern. These results indicate that the fate of the reconstructed arteries of the lower limb could be predicted by flow waveform analysis, and a careful and serial postoperative evaluation of the graft should be made, particularly those with type II, III or IV flow waveform patterns.     

Gram-negative infections of arterial substitutes

Enteric contamination at the site of a vascular injury creates a difficult management problem. In order to more intelligently approach this problem we have compared the efficacy of arterial autografts, autogenous vein graft, and polytetrafluorethylene (PTFE) grafts in wounds contaminated with enteric organisms. Thirty mongrel dogs were divided into three groups. Group I had both femoral arteries replaced with autografts, Group II underwent bypass grafting with 4-mm PTFE grafts, and Group III had femoral arteries replaced with autogenous vein grafts. The right groin was closed aseptically and served as a control while the left groin was contaminated with a standard aliquot of stool and then closed. The groups were observed for loss of blood flow, death due to hemorrhage, or complete healing. Termination of the study was determined by the first of these to occur in each animal. In the animals with arterial autografts, seven demonstrated healing and the average time to termination of the study was 20.2 days. Only one of the PTFE grafts healed and the average survival was 8.9 days. In the group with vein grafts, five healed. The time to termination was 14.7 days. These data demonstrated that arterial autografts are superior to PTFE grafts in an infected wound due to their ability to heal without disruption. This study suggests that autogenous tissue grafts are the prostheses of choice for replacement of small vessels injured in the presence of significant contamination.     

In vitro laser recanalization of chronically occluded prosthetic grafts.

Polytetrafluoroethylene (PTFE) and Dacron grafts were implanted in canine femoral and carotid arteries using PTFE and Prolene suture, respectively. Arteries containing occluded grafts were explanted and laser recanalization was attempted in vitro. Laser recanalization was successful in 78% of PTFE grafts compared to 30% of Dacron grafts. Recanalization was complete (residual stenosis less than 5%) in opened PTFE grafts, whereas residual stenosis averaged 60% in recanalized Dacron grafts. PTFE graft/PTFE suture anastomotic tensile strength was unchanged after recanalization, while Dacron graft/Prolene suture anastomotic tensile strength decreased significantly. In addition, anastomotic bursting pressure was significantly higher for lased PTFE grafts with PTFE sutures (300 mg Hg) compared to lased Dacron grafts with Prolene sutures (70 mm Hg). Chronically occluded PTFE grafts with PTFE suture can be safely and effectively opened by laser recanalization. In contrast, attempted laser recanalization of Dacron grafts sutured with Prolene suture is seldom successful, significantly weakens the graft artery anastomosis, and should be avoided.     

A novel perfusion system for the endothelialisation of PTFE grafts under defined flow.

OBJECTIVES: to develop a perfusion system for culturing human endothelial cells on small-diameter PTFE grafts under defined pulsatile shear stress. METHODS: to benefit from a stronger adhesion of endothelial cells to the substrate, we developed a perfusion system which enables culture of endothelial cells on PTFE grafts to confluence under a wide range of shear stress. We also developed an in situ staining method for the determination of the endothelialisation stage by upper light microscopy. RESULTS: the application of pulsatile flow with high shear stress (6.6 dyn/cm2, 5 min) to a graft endothelialised under perfusion did not lead to a disruption of the confluent cell layer. In contrast, a shear stress of 3 dyn/cm2 applied for 5 min was sufficient to wash more than 50% of endothelial cells off the PTFE graft when cultured to confluence under static conditions. CONCLUSIONS: this technique induces a stronger cell adherence of endothelial cells to a PTFE graft in comparison with grafts endothelialised under static conditions. Endothelialised vascular grafts can be pre-conditioned to defined shear stress values.     

Increased risk of infection associated with polyurethane dialysis grafts

Conventional polytetrafluoroethylene (PTFE) dialysis grafts cannot be cannulated for 2-3 weeks following their creation. Polyurethane grafts, made of a self-sealing material, can be cannulated within 24 hours of implantation, representing a potential advantage in patients with limited catheter options. However, early cannulation may increase the risk of graft infection. We retrospectively queried a prospective, computerized access database to identify 31 patients receiving a polyurethane graft, and 56 date-matched controls with a PTFE graft. Survival techniques were used to plot graft survival. Thrombosis-free graft survival (from creation to first thrombosis or failure) was similar for polyurethane and PTFE grafts (1-year survival, 28%, vs. 32%, p = 0.98). Cumulative graft survival (from creation to permanent failure) was also similar (1-year survival 42% vs. 52%, p = 0.40). Finally, the cumulative risk of graft infection was 37.5% for polyurethane thigh grafts, 23% for polyurethane upper extremity grafts, 21% for PTFE thigh grafts, and 5% for PTFE upper extremity grafts (p = 0.06 for polyurethane vs. PTFE grafts). The likelihood of thrombosis and failure is similar for polyurethane and PTFE grafts. However, polyurethane grafts may have a higher risk of infection, particularly when they are placed in the thigh. In patients with an access emergency, implantation of a polyurethane graft incurs a tradeoff between earlier cannulation and a higher risk of infection.     

Prevention and management of polytetrafluoroethylene graft complications in peripheral vascular reconstruction

The use of expanded PTFE grafts as a vascular substitute has been well established. PTFE is an acceptable alternative for patients in whom the saphenous vein is unusable. Nonreinforced PTFE grafts do a better job of resisting infection, permitting cellular ingrowth, and allowing the development of a true neointima. During a 6 year period ending in April 1981, 129 grafts were placed in various positions. Most of these were placed primarily in the femoropopliteal position. One death occurred as a direct result of the surgery. Only two infections were encountered, both were delayed and patient-induced.There were no true aneurysms in the PTFE grafts of our patients. The use of smooth noncrushing clamps applied gently with just enough pressure to stop blood flow will lessen the likelihood of aneurysmal formation. Careful surgical technique can minimize problems. False aneurysm in vascular reconstruction can largely be prevented by the proper establishment of hemostasis at the suture line. Selection of an appropriate needle and suture along with the use of proper technique in their placement will help provide the best possible results. One should follow the curve of the needle at the time of suturing to help prevent elongation of the suture holes, which may contribute to difficulties in establishing hemostasis at the suture line. Thrombosis is the most common problem associated with the use of this graft: correction requires careful balloon catheter techniques. Salvage of the graft can be obtained by endarterectomy, patch grafting, or jump grafts so that the entire prosthesis does not have to be replaced.     

Influence of prosthetic graft fabrication on graft healing,I

The object of this report was to analyze graft healing by comparing the content of collagen and noncollagen protein among seven commonly used prostheses: light-weight knitted dacron concentric crimp (USCI), Sauvage filimentous external velour knitted dacron with concentric crimp, random crimp, or no crimp (USCI), microvel double-velour knitted dacron concentric crimp (Meadox), PTFE Impra, and PTFE Gortex. Grafts (6 mm) were used to replace 4-cm segments of infrarenal abdominal aorta in 85 experimental dogs and five autograft aorta control animals. At 3 and 6 months postimplantation the grafts were aseptically harvested, inspected for completeness of neointimal healing and submitted for biochemical analysis. After 3 months implantation, uncrimped external velour grafts had less hydroxyproline than all dacron grafts except random crimp external velour (P < 0.05) but not less than both PTFE grafts and most dacron and PTFE grafts were not significantly different in noncollagen protein. After 6 months implantation, all dacron grafts had more hydroxyproline than both PTFE grafts (P < 0.03) and most dacron grafts had significantly more noncollagen protein than PTFE Impra (P < 0.05). Of all the grafts analyzed, only uncrimped external velour knitted dacron grafts had both rapid neoendothelial healing and a significant increase in both hydroxyproline and noncollagen protein between 3 and 6 months after graft implantation (P < 0.01). These data indicate that dacron prostheses heal in a manner different from that of PTFE grafts, that there may be differences among the various types of dacron prostheses, and that external velour uncrimped grafts would appear to have the best healing characteristics.     

Comparison of polytetrafluoroethylene (PTFE) and dacron as long, small-diameter arterial grafts in dogs

A canine model in which joined carotid arteries were anastomosed to 6-mm grafts (average length, 45 cm) of polytetrafluoroethylene (PTFE) or Dacron double velour and the grafts were anastomosed to the ligated distal abdominal aorta was used to study long-term graft patency. The 16 dogs with PTFE grafts and the 15 dogs with Dacron grafts were sacrificed at three-, six-, and 12-month intervals, or whenever a graft occluded. At three months, eight of 11 PTFE and 11 of 11 Dacron grafts were patent; at six months, two of three PTFE and three of three Dacron grafts were patent; at 12 months, one of two PTFE grafts and the one remaining Dacron graft were patent. All grafts were examined grossly and microscopically. The PTFE grafts showed increasing degrees of calcification and intimal fibrin deposition; the Dacron grafts had no calcification and less intimal fibrin deposition. The model was satisfactory for studying long, small-diameter vascular grafts, but PTFE was not found to be superior to Dacron in this study.     

Clinical trials of a new polytetrafluoroethylene-silicone graft

A self-sealing polytetrafluoroethelene (PTFE)-silicone graft designed to be used early after implantation was placed in 30 end-stage renal disease patients. Thirty-five conventional PTFE grafts were used in the control group. All patients were followed for 1 year. In the PTFE-silicone graft group, median time for first use was 1 day after implantation. Conventional PTFE grafts were first used 2 to 4 weeks after implantation. Early punctures of the PTFE-silicone grafts (first 10 sessions), although more difficult to perform than late punctures, were not more difficult than punctures of conventional PTFE grafts. Late punctures in PTFE-silicone grafts were easier than conventional PTFE graft punctures. Bleeding after needle removal was significantly decreased after early and late punctures of PTFE-silicone grafts compared with conventional PTFE grafts (p less than 0.001). The PTFE-silicone graft can be used immediately after implantation, sparing patients additional access procedures for short-term dialysis. This results in less morbidity, decreased bleeding complications, shorter hospital stay, and a significant reduction in expenses.     

In vivo study of an elastomer end-coated polytetrafluoroethylene vascular prosthesis.

Polyurethane end-coated polytetrafluoroethylene (PTFE) grafts (elastomer PTFE grafts) were implanted in 12 female adult mongrel dogs to assess patency, intimalization, tissue incorporation, and technical suitability of the material as a vascular graft. Each dog had bilateral aortoiliac grafts placed, one a standard PTFE and the other an elastomer PTFE graft. The length of the grafts was 7-8 cm and the diameter was 6 mm. The grafts were harvested at intervals to 120 days postoperatively. The elastomer PTFE grafts showed superior longitudinal elasticity, retention of shape, and no graft tearing with suture tension; however, no significant difference in bleeding was noted at the anastomoses between the standard and elastomer PTFE grafts. Satisfactory patency was obtained with both standard (8/10) and elastomer PTFE grafts (9/10) at 90-120 days. No significant difference in the thickness of intima and the length of pannus ingrowth was noted between the standard and elastomer PTFE grafts. No outer tissue incorporation was seen at the elastomer-treated graft segments as opposed to the well-incorporated untreated segments. In conclusion, elastomer end-coating of a PTFE vascular prosthesis provided excellent handling characteristics without detracting from patency; however, the lack of outer tissue incorporation may be a potential disadvantage in its clinical use.     

The consequences of a failed femoropopliteal bypass grafting: comparison of saphenous vein and PTFE grafts

OBJECTIVES: Although there are numerous reports comparing saphenous vein (SV) and polytetrafluoroethylene (PTFE) with respect to the patency rates for femoropopliteal bypass grafts, the clinical consequences of failed grafts are not as well described. This study compares the outcomes of failed SV and PTFE grafts with a specific emphasis on the degree of acute limb ischemia caused by graft occlusion. METHODS: Over a 6-year period, 718 infrainguinal revascularization procedures were performed, of which 189 were femoropopliteal bypass grafts (SV, 108; PTFE, 81). Society for Vascular Surgery/International Society for Cardiovascular Surgery (SVS/ISCVS) standardized runoff scores were calculated from preoperative arteriograms. Clinical categories of acute limb ischemia resulting from graft occlusion were graded according to SVS/ISCVS standards (I, viable; II, threatened; III, irreversible). Primary graft patency and limb salvage rates at 48 months were calculated according to the Kaplan-Meier method. RESULTS: Patients were well matched for age, sex, and comorbidities. Chronic critical ischemia was the operative indication in most cases (SV, 82%; PTFE, 80%; P =.85). Runoff scores and preoperative ankle-brachial index measurements were similar for the two groups (SV, 6.0 +/- 2.5 [SD] and 0.51 +/- 0.29; PTFE, 5.3 +/- 2.8 and 0.45 +/- 0.20; P =.06 and P =.12). The distal anastomosis was made below the knee in 60% of SV grafts and 16% of PTFE grafts (P <.001). Grade II ischemia was more likely to occur after occlusion of PTFE grafts (78%) than after occlusion of SV grafts (21%; P =.001). Emergency revascularization after graft occlusion was required for 28% of PTFE failures but only 3% of SV graft failures (P <.001). Primary graft patency at 48 months was 58% for SV grafts and 32% for PTFE grafts (P =.008). Limb salvage was achieved in 81% of SV grafts but only 56% of PTFE grafts (P =.019). CONCLUSIONS: Patients undergoing femoropopliteal bypass grafting with PTFE are at greater risk of ischemic complications from graft occlusion and more frequently require emergency limb revascularization as a result of graft occlusion than patients receiving SV grafts. Graft patency and limb salvage are superior with SV in comparison with PTFE in patients undergoing femoropopliteal bypass grafting.     

New prostheses for use in bypass grafts with special emphasis on polyurethanes

Vascular bypass procedures using traditional prosthetic grafts such as polytetrafluoroethylen (PTFE) and polyethylene tetraphthlate (Dacron) are prone to failure when used in low flow states such as in below knee bypass and when the diameter of the graft is less than 6 mm. A major factor in this is compliance mismatch between the graft and the diseased vessel, which may cause intimal hyperplasia at the distal anastomosis. PTFE and Dacron are rigid grafts with poor compliance. By improving the compliance of the prosthetic graft it is hoped that patency will improve. Recent advances in polyurethane chemistry have developed materials that do not degrade and which allow compliance matching of the graft to the patient's vasculature. It is now possible to manufacture biologically and haemodynamically compatible grafts with small diameter from these polyurethane graft materials. This review will focus on the lack of compliance in current vascular bypass grafts and the promise of the new polyurethane polymers in a new generation of small-bore bypass grafts.     

双层血管细胞种植提高人工血管内皮细胞粘附性

目的　采用血管内皮细胞 (EC)和平滑肌细胞 (SMC)双层种植方法 ,提高人工血管腔面EC的保存率。　方法　聚四氟乙烯 (PTFE)人工血管经纤维连结蛋白预衬处理 ,管腔面先后种植SMC和EC ,将受试的人工血管接入脉冲式体外灌注装置灌注 1h ,计算比较灌注前后受试标本SMC和EC密度。　结果　灌注 1h后 ,单纯EC种植组 61%细胞脱落 ,单纯SMC种植组 3 6%细胞脱落 ,而双层细胞种植组仅有 2 7%EC脱落 ,双层细胞种植组细胞保存率明显高于单纯EC种植组 (P <0 0 1)。低流速预灌注未能改善EC的保存率。　结论　在EC和人工血管壁之间种植SMC可提高EC的保存率     

Bovine carotid artery heterografts versus polytetrafluoroethylene grafts. A prospective, randomized study

A prospective, randomized comparison of BCAH and PTFE vascular access grafts resulted in no statistically significant difference when analyzed for survival rates of complications, types of complications, reasons for failure, and clot salvageability. The results in diabetic patients were similar to those in nondiabetic patients. The majority of retrospective studies and subjective experiences favor PTFE grafts over BCAHs. The explanation may be part that BCAH preceded PTFE grafts into clinical use, and inexperience in the operating room and in the dialysis unit had an effect on BCAH results. A review of impressions of the graft materials indicated a decided preference for PTFE grafts.